Breadcrumb Home / Investors & Media / Investors & Media / Press releases Press releases Explore Investors & Media Explore Investors & Media Investor Overview Press Releases Archived Press Releases Events & Presentations Corporate Governance Committee Composition Management Team Board of Directors Financials & Filings SEC Filings Stock Information Historical Stock Lookup Investment Calculator Analyst Coverage Investor FAQs Contact IR or Media Year None20242023202220212020201920182017 August 8, 2018 Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress Read This Press Release August 2, 2018 Scholar Rock to Participate in Upcoming Investor Conferences Read This Press Release June 4, 2018 Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering Read This Press Release May 31, 2018 Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015 Read This Press Release May 23, 2018 Scholar Rock Announces Pricing of Initial Public Offering Read This Press Release April 9, 2018 Scholar Rock Appoints Rhonda Chicko as Chief Financial Officer Read This Press Release March 29, 2018 Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy Read This Press Release February 2, 2018 Scholar Rock Announces Publication of Comprehensive Pharmacological Study of SRK-015, a Novel Inhibitor of Myostatin Activation, Supporting the Treatment of Muscle Atrophy Disorders Read This Press Release Pagination First page « first Previous page ‹ previous … Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Next page next › Last page last » RSS Feeds Search
Year None20242023202220212020201920182017 August 8, 2018 Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress Read This Press Release August 2, 2018 Scholar Rock to Participate in Upcoming Investor Conferences Read This Press Release June 4, 2018 Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering Read This Press Release May 31, 2018 Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015 Read This Press Release May 23, 2018 Scholar Rock Announces Pricing of Initial Public Offering Read This Press Release April 9, 2018 Scholar Rock Appoints Rhonda Chicko as Chief Financial Officer Read This Press Release March 29, 2018 Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy Read This Press Release February 2, 2018 Scholar Rock Announces Publication of Comprehensive Pharmacological Study of SRK-015, a Novel Inhibitor of Myostatin Activation, Supporting the Treatment of Muscle Atrophy Disorders Read This Press Release Pagination First page « first Previous page ‹ previous … Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Next page next › Last page last »